Recurrent tumor mutations in the Hippo pathway through loss of function (LOF) of LATS or NF2 or YAP amplification/over expression result in constitutive upregulation of TEAD/YAP transcription and acquisition of the transformed phenotype in culture5 and in mouse genetic models in vivo6. The gene discussed is NF2; the disease is neoplasm.